Dr. Andrew M Lin , MD
Dermatology โข Seattle, WA
201 16th Ave E
Seattle, WA 981125226
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
NPI assigned on March 27, 2013; this date does not establish years in practice.
-
Published CMS data list 2,956 Original Medicare Part B services in 2022.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2022. Published rows only; this is not a quality measure.
-
Published Part B service records, 2022:
- 17003 โ Destruction of precancer skin growth, 2-14 growths: 1,223 service units.
- 99213 โ Established patient outpatient office visit: 300 service units.
- 17000 โ Destruction of precancer skin growth, 1 growth: 285 service units.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2022. Units differ by code; these are not visits or a measure of quality.
CPTยฎ only copyright 2021 American Medical Association. All rights reserved. Service names are shortened from CPT Consumer Friendly Descriptors (CMS data, 2022). CPT notice
See all 15 records in the table ยท Guide: How to read Medicare Part B data
-
Published CMS data list 380 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers โ by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Ketoconazole โ 83 prescription fills, including refills.
- Fluorouracil โ 59 prescription fills, including refills.
- Triamcinolone Acetonide โ 54 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers โ by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 10 records in the table ยท Guide: How to read Medicare Part D prescriber data
-
Close to the middle for Part D prescriptions among clinicians listed under Dermatology in Seattle, WA (2024, 87 clinicians with data). Median for this group: 404. Middle half: 194 to 708.
Fewer Part D prescriptions than 60% of clinicians listed under Dermatology in Washington (2024, 278 clinicians with data). Median for this group: 484. Middle half: 214 to 862.
Source: CMS, Medicare Part D Prescribers โ by Provider and Drug, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part B services went from 12 in 2019 to 2,956 in 2022.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2019โ2022.
Practice Location & Contact Primary Location
201 16th Ave E
Seattle, WA 981125226
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
NPPES lists 1 additional practice-address record in Las Vegas, NV. See the list
Source: CMS NPPES NPI Registry, practice location records; release date unavailable.
CMS Doctors and Clinicians lists 1 group name: Kaiser Foundation Health Plan Of Washington. See the list
Source: CMS Doctors and Clinicians National Downloadable File, release date unavailable.
Listings do not confirm current availability, employment or a shared ownership network.
Medicare Profile & Education
Source: CMS Doctors and Clinicians National Downloadable File
2013
What Public CMS Data Show
Dermatology: NPPES taxonomy is a reported classification, not proof of board certification.
Medicare-allowed amount
About $188,201 in 2022
The total amount Medicare approved for these services in 2022. It includes what Medicare paid and what patients or their other insurance owed, such as the deductible and coinsurance.
It shows the total cost of this clinician's Original Medicare services under Medicare's fee rules.
What this does not show: Medicare-allowed amount
This is not the clinician's income. Part of it can go to a clinic or group practice, staff, equipment or drugs. It is not the price you will pay.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2022.
Paid by Medicare
About $137,886 in 2022
The part of the Medicare-allowed amount that Medicare itself paid in 2022, after patients' deductibles and coinsurance.
The gap between the allowed amount and this number is roughly what patients and their other insurance paid.
What this does not show: Paid by Medicare
This is not the clinician's income and not a measure of quality.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2022.
30-day fills
429 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$143,111 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers โ by Provider and Drug, 2024.
Open Payments general payments, program year 2024
All general payments: $439.87 across 67 records.
By nature of payment
- Food and Beverage: $439.87 across 67 records.
Reporting-company totals
- Bristol Myers Squibb Company: $376.45 across 66 records.
- Eli Lilly and Company: $63.42 across 1 record.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2024 (published June 30, 2026).
Years since graduation
13 years (graduated 2013)
CMS Doctors and Clinicians data list 2013 as the year this clinician finished professional school.
It tells you roughly how long ago the clinician finished school.
What this does not show: Years since graduation
It is not the number of years in practice, and more years does not mean better care.
Source: CMS Doctors and Clinicians National Downloadable File.
NPI first issued
2013
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Accepts Medicare assignment
CMS data list this clinician as accepting Medicare assignment. This means agreeing to take the Medicare-approved amount as full payment for covered services.
With Original Medicare, you usually pay only your deductible and coinsurance, and the office sends the claim to Medicare for you.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians; Medicare.gov, โDoes your provider accept Medicare as full payment?โ
No telehealth indicator
CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians.
Enrolled in Medicare (PECOS)
Dr. Lin has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.
It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Can order Medicare-covered services
CMS lists Dr. Lin as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.
Medicare pays for these items and services only when they are ordered by an eligible clinician.
What this does not show: Can order Medicare-covered services
It does not mean the clinician offers these services directly.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Compared with the same specialty in Seattle and Washington
Billing and prescribing volume is not a quality rating.
Medicare Part D prescriptions
Close to the middle for clinicians listed under Dermatology in Seattle, WA (2024, 87 clinicians with data). Median for this group: 404. Middle half: 194 to 708.
Fewer Part D prescriptions than 60% of clinicians listed under Dermatology in Washington (2024, 278 clinicians with data). Median for this group: 484. Middle half: 214 to 862.
Part D drug cost
A higher Part D drug cost than 65% of clinicians listed under Dermatology in Seattle, WA (2024, 87 clinicians with data). Median for this group: $68,797. Middle half: $8,056 to $179,815.
A higher Part D drug cost than 65% of clinicians listed under Dermatology in Washington (2024, 278 clinicians with data). Median for this group: $65,882. Middle half: $7,804 to $224,271.
Medicare Part B
Comparisons use 2024 data. The latest CMS data for Dr. Lin are from 2022.
120 active clinicians are listed under Dermatology with a practice address in Seattle, WA (384 in Washington).
Addresses are self-reported to NPPES and may be out of date.
Telehealth indicator in Seattle
29.2% of these 120 clinicians have the CMS telehealth indicator.
69.2% of these 120 clinicians are listed by CMS as accepting Medicare assignment.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part B services
Medicare Part B services went from 12 in 2019 to 2,956 in 2022.
- 2019: 12
- 2020: 587
- 2021: 2,194
- 2022: 2,956
-
Medicare-allowed amount
Medicare-allowed amount went from $928 in 2019 to $188,201 in 2022.
- 2019: $928
- 2020: $30,144
- 2021: $133,395
- 2022: $188,201
-
Paid by Medicare
Paid by Medicare went from $739 in 2019 to $137,886 in 2022.
- 2019: $739
- 2020: $21,159
- 2021: $100,771
- 2022: $137,886
-
Medicare Part D prescriptions
Medicare Part D prescriptions increased 11% from 342 in 2020 to 380 in 2024.
- 2020: 342
- 2021: 367
- 2022: 376
- 2023: 295
- 2024: 380
-
30-day fills
30-day fills varied from year to year: 424 in 2020 and 429 in 2024.
- 2020: 424
- 2021: 400
- 2022: 395
- 2023: 330
- 2024: 429
-
Part D drug cost
Part D drug cost increased 808% from $15,764 in 2020 to $143,111 in 2024.
- 2020: $15,764
- 2021: $85,186
- 2022: $305,708
- 2023: $300,174
- 2024: $143,111
-
Industry payments (Open Payments)
Industry payments (Open Payments) went from $20.71 in 2020 to $439.87 in 2024.
- 2020: $20.71
- 2021: $1,430.37
- 2022: $16,332.51
- 2023: $539.34
- 2024: $439.87
Sources: CMS Medicare Physician & Other Practitioners (2022), CMS Medicare Part D Prescribers (2024), CMS Open Payments (2024), CMS Doctors and Clinicians, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo ยท Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2024 (payments made January 1 โ December 31, 2024): 67 records totaling $439.87.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| Eli Lilly and Company |
Food and Beverage
In-kind items and services
|
OLUMIANT | General | $63.42 |
| Bristol Myers Squibb Company |
Food and Beverage
Cash or cash equivalent
|
Sotyktu | General | $28.46 |
| Bristol Myers Squibb Company |
Food and Beverage
Cash or cash equivalent
|
Sotyktu | General | $23.95 |
| Bristol Myers Squibb Company |
Food and Beverage
Cash or cash equivalent
|
โ | General | $22.52 |
| Bristol Myers Squibb Company |
Food and Beverage
Cash or cash equivalent
|
Sotyktu | General | $22.15 |
| Bristol Myers Squibb Company |
Food and Beverage
Cash or cash equivalent
|
Sotyktu | General | $21.94 |
| Bristol Myers Squibb Company |
Food and Beverage
Cash or cash equivalent
|
Sotyktu | General | $21.03 |
| Bristol Myers Squibb Company |
Food and Beverage
Cash or cash equivalent
|
Sotyktu | General | $19.68 |
| Bristol Myers Squibb Company |
Food and Beverage
Cash or cash equivalent
|
Sotyktu | General | $18.43 |
| Bristol Myers Squibb Company |
Food and Beverage
Cash or cash equivalent
|
Sotyktu | General | $17.31 |
| Bristol Myers Squibb Company |
Food and Beverage
Cash or cash equivalent
|
Sotyktu | General | $16.49 |
| Bristol Myers Squibb Company |
Food and Beverage
Cash or cash equivalent
|
Sotyktu | General | $15.15 |
| Bristol Myers Squibb Company |
Food and Beverage
Cash or cash equivalent
|
Sotyktu | General | $12.55 |
| Bristol Myers Squibb Company |
Food and Beverage
Cash or cash equivalent
|
Sotyktu | General | $11.85 |
| Bristol Myers Squibb Company |
Food and Beverage
Cash or cash equivalent
|
Sotyktu | General | $11.25 |
| Bristol Myers Squibb Company |
Food and Beverage
Cash or cash equivalent
|
Sotyktu | General | $10.37 |
| Bristol Myers Squibb Company |
Food and Beverage
Cash or cash equivalent
|
Sotyktu | General | $9.79 |
| Bristol Myers Squibb Company |
Food and Beverage
Cash or cash equivalent
|
Sotyktu | General | $9.73 |
| Bristol Myers Squibb Company |
Food and Beverage
Cash or cash equivalent
|
Sotyktu | General | $8.00 |
| Bristol Myers Squibb Company |
Food and Beverage
Cash or cash equivalent
|
Sotyktu | General | $4.34 |
| Bristol Myers Squibb Company |
Food and Beverage
Cash or cash equivalent
|
Sotyktu | General | $3.69 |
| Bristol Myers Squibb Company |
Food and Beverage
Cash or cash equivalent
|
Sotyktu | General | $3.46 |
| Bristol Myers Squibb Company |
Food and Beverage
Cash or cash equivalent
|
Sotyktu | General | $3.28 |
| Bristol Myers Squibb Company |
Food and Beverage
Cash or cash equivalent
|
Sotyktu | General | $3.21 |
| Bristol Myers Squibb Company |
Food and Beverage
Cash or cash equivalent
|
Sotyktu | General | $3.14 |
(top 25 shown)
Source: CMS Open Payments, program year 2024, released June 30, 2026.
Performed Procedures & Service Volume
CPTยฎ is a registered trademark of the American Medical Association. CPT codes, descriptions and other data only are copyright 2018โ2021 American Medical Association. All rights reserved. Applicable FARS/HHSARS apply. Descriptions of CPT codes are the AMA's CPT Consumer Friendly Descriptors as published by CMS in the Medicare Physician & Other Practitioners โ by Provider and Service data, 2019โ2022; they are plain-language summaries, not for clinical coding or documentation. HCPCS Level II codes and descriptions are from CMS. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
| HCPCS Code | Services | Patients | Submitted Charge | Medicare Allowed |
|---|---|---|---|---|
|
17003
Destruction of precancer skin growth, 2-14 growths
|
1,223 | 191 | $12.11 | $6.85 |
|
99213
Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
|
300 | 231 | $162.43 | $92.54 |
|
17000
Destruction of precancer skin growth, 1 growth
|
285 | 232 | $122.39 | $54.52 |
|
99214
Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
|
219 | 153 | $228.76 | $130.27 |
|
88305
Pathology examination of tissue using a microscope, intermediate complexity
|
154 | 86 | $126.60 | $71.55 |
|
11102
Biopsy of related skin growth, first growth
|
148 | 129 | $187.59 | $95.55 |
|
17110
Destruction of skin growth, 1-14 growths
|
141 | 118 | $205.69 | $111.31 |
|
99203
New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more
|
136 | 136 | $202.65 | $114.72 |
|
11103
Biopsy of related skin growth, each additional growth
|
102 | 56 | $93.04 | $52.62 |
|
17004
Destruction of precancer skin growth, 15 or more growths
|
93 | 80 | $305.09 | $173.15 |
|
99204
New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
|
81 | 81 | $304.77 | $171.45 |
|
11602
Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm
|
24 | 20 | $445.71 | $126.07 |
|
17262
Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm
|
24 | 20 | $324.50 | $156.84 |
|
12032
Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm
|
15 | 11 | $552.30 | $303.48 |
|
13121
Complicated repair of wound of scalp, arms, or legs, 2.6-7.5 cm
|
11 | 11 | $779.87 | $439.81 |
Source: CMS Part B by Provider and Service, 2022; services under 11 beneficiaries omitted by CMS. Privacy limits
Submitted charges are billed amounts, not a price quote for your visit.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Ketoconazole | Ketoconazole | 83 | 2,517 | $1,676.30 | 53 |
| Fluorouracil | Fluorouracil | 59 | 1,461 | $2,631.28 | 49 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 54 | 1,652 | $1,415.68 | 40 |
| Clobetasol Propionate | Clobetasol Propionate | 51 | 1,342 | $1,297.62 | 27 |
| Hydrocortisone | Hydrocortisone | 29 | 790 | $1,001.87 | 25 |
| Fluocinonide | Fluocinonide | 28 | 1,038 | $547.45 | 16 |
| Dupixent Pen | Dupilumab | 25 | 702 | $91,701.83 | โ |
| Doxycycline Monohydrate | Doxycycline Monohydrate | 20 | 1,136 | $598.02 | 12 |
| Tacrolimus | Tacrolimus | 20 | 554 | $1,655.45 | 11 |
| Adbry | Tralokinumab-Ldrm | 11 | 308 | $40,585.00 | โ |
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
Self-certified to NPPES: 2022-12-08NUCC Taxonomy Code: 207N00000X
A dermatologist is trained to diagnose and treat pediatric and adult patients with benign and malignant disorders of the skin, mouth, external genitalia, hair and nails, as well as a number of sexually transmitted diseases. The dermatologist has had additional training and experience in the diagnosis and treatment of skin cancers, melanomas, moles and other tumors of the skin, the management of contact dermatitis and other allergic and nonallergic skin disorders, and in the recognition of the skin manifestations of systemic (including internal malignancy) and infectious diseases. Dermatologists have special training in dermatopathology and in the surgical techniques used in dermatology. They also have expertise in the management of cosmetic disorders of the skin such as hair loss and scars and the skin changes associated with aging.
Medicare (PECOS) Enrollment & Ordering Eligibility
Source: CMS PECOSPRACTITIONER - DERMATOLOGY
I20221130003323
WA
4486969334
Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.
Medicare Group Practice Enrollments
Source: CMS Doctors and Clinicians National Downloadable File
Kaiser Foundation Health Plan Of Washington
125 16th Ave E, Seattle, WA 981125211
Phone: 2063262662
Secondary Practice Locations
6460 Medical Center St Ste 350
Las Vegas, NV 891482423
Phone: 7022556647
Clinicians Sharing This Practice Address or Phone
Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.
Internal Medicine - Gastroenterology
Doctor of Medicine (M.D.)
Physician Assistant - Surgical
Physician Assistant (Certified)
Hospitalist
Doctor of Medicine (M.D.)
Nurse Anesthetist, Certified Registered
Certified Registered Nurse Anesthetist
Physical Medicine & Rehabilitation
Doctor of Medicine (M.D.)
Emergency Medicine
Doctor of Medicine (M.D.)
Career & Practice History Timeline
Changes recorded in monthly NPPES data files: addresses, names, credentials, specialties and NPI status
Registered at 201 16TH AVE E, SEATTLE, WA 981125226 (Tel: 2063263000)
Registered at 6460 MEDICAL CENTER ST STE 350, LAS VEGAS, NV 891482423 (Tel: 7022556647)
Registered at 6460 MEDICAL CENTER ST STE 350, LAS VEGAS, NV 891482423 (Tel: 7022556647)
Dermatology (license number reported to NPPES: NV 21126)
NPI status registered as active in NPPES database
Registered at 5601 DE SOTO AVE, WOODLAND HILLS, CA 913675000 (Tel: (818) 719-2000)
Registered at 5601 DE SOTO AVE, WOODLAND HILLS, CA 91367 (Tel: (818) 719-2000)
Recorded as ANDREW LIN, M.D.
Dermatology (license number reported to NPPES: CA A147112)
NPI status registered as active in NPPES database
Registered at 1500 E MEDICAL CENTER DR, 1910 TAUBMAN CENTER, ANN ARBOR, MI 481095000 (Tel: 7349366674)
Registered at 1500 E MEDICAL CENTER DR, ANN ARBOR, MI 481095000 (Tel: 7349366674)
Recorded as ANDREW LIN, M.D.
Dermatology (license number reported to NPPES: MI 4301106224)
First registered as active Individual Practitioner in NPPES Database.
NPI Administrative Meta
Other Dermatology Specialists in Seattle
- Dr. Galina Stetsenko, MD, MHA
- Dr. Rachel Wheatley, MD
- Paul Nghiem
- Dr. Ulrike Ochs, MD
- Dr. Soo Jung Kim, MD PHD
- Dr. Vivian Shi, MD
Mailing Address
6460 Medical Center St Ste 350
Las Vegas, NV 891482423
Phone: 7022556647